Non-invasive in vivo determination of viable islet graft volume by 111In-exendin-3

Non-invasive in vivo determination of viable islet graft volume by 111In-exendin-3

Abstract Pancreatic islet transplantation is a promising therapy for patients with type 1 diabetes. However, the duration of long-term graft survival is limited due to inflammatory as well as non-inflammatory processes and routine clinical tests are not suitable to monitor islet survival. 111In-exen...

Full description

Bibliographic Details
Main Authors: Wael A. Eter, Inge Van der Kroon, Karolina Andralojc, Mijke Buitinga, Stefanie M. A. Willekens, Cathelijne Frielink, Desiree Bos, Lieke Joosten, Otto C. Boerman, Maarten Brom, Martin Gotthardt
Format: Article
Language:English
Published: Nature Publishing Group 2017-08-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-017-07815-3

Internet

https://doi.org/10.1038/s41598-017-07815-3

Similar Items